Latest News and Press Releases

PLANTATION, Fla., Sept. 14, 2009 (GLOBE NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) announced today the completion of the cGMP manufacturing and vialing of AREVA Med's monoclonal antibody-chelator...

PLANTATION, Fla., Dec. 12, 2008 (GLOBE NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) announced today the successful completion of the development work for the new AREVA drug that will be radio-labeled...

PLANTATION, Fla., 12. Dez. 2008 (GLOBE NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) hat heute die erfolgreiche Beendigung der Entwicklungsarbeit für das neue AREVA Medikament bekannt gegeben, das...

Goodwin Biotechnology Inc. achève le développement du nouveau traitement contre le cancer d'AREVA PLANTATION, Floride, le 12 décembre 2008 (GLOBE NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI)...

PLANTATION, Fla., Dec. 12, 2008 (GLOBE NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) announced today the successful completion of the development work for the new AREVA drug that will be...

PLANTATION, Fla., July 21, 2008 (PRIME NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) today announced that the melanin-binding IgM antibody manufactured by the company was used in a successful Phase I...

PLANTATION, Fla., June 30, 2008 (PRIME NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) disclosed today that it has begun process development toward AREVA's lead-212 initiative to treat cancer. As part...